Skip to content

A prospective, single-center, open, randomized, parallel controlled, exploratory clinical trial evaluating the safety and effectiveness of bone glue for reduction and fixation of comminuted distal radius fractures

A prospective, single-center, open, randomized, parallel controlled, exploratory clinical trial evaluating the safety and effectiveness of bone glue for reduction and fixation of comminuted distal radius fractures

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500098530
Enrollment
Unknown
Registered
2025-03-10
Start date
2025-03-12
Completion date
Unknown
Last updated
2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

comminuted distal radius fractures

Interventions

Sponsors

The Affiliated Sir Run Run Shaw Hospital of Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) Age >= 18 years and <= 65 years, gender unrestricted; 2) Comminuted distal radius fractures caused by various, requiring fracture reduction and fixation surgery; 3) The participant or their legal representative can understand the purpose of the study, demonstrates sufficient compliance with the study protocol, signs the informed consent form.

Exclusion criteria

Exclusion criteria: 1) Combining systemic infection or uncontrolled local infection, severe soft tissue damage at the proposed surgical site, severe vascular or nerve damage, malignant tumor, diagnosed severe malnutrition or other important organ failure; 2) Previous history of distal radius fractures on the same wrist; 3) Open distal radius fracture; 4) Combining hand injuries with navicular bone fractures or other factors that affect functional recovery; 5) Take oral or injection sedatives, hypnotics, or nonsteroidal anti-inflammatory drugs (excluding aspirin) every week within the first 3 months of screening; 6) Have received chemotherapy drugs or radiation therapy within the previous 3 months or during the screening period; 7) Accumulated oral or injectable corticosteroids or various growth factors for at least 14 days within the month prior to screening or during the screening period; 8) The limb to be operated on is complicated with osteofascial compartment syndrome; 9) Merge bone defects planned for non autogenous bone implantation; 10) Pregnant or lactating women; 11) Combining severe heart, lung, liver, kidney, hematological or metabolic diseases that cannot tolerate surgery; 12) Screening for participation in other clinical trials that may affect this trial within the previous 3 months; 13) For the benefit of the subjects, the researchers believe that they should not participate in other situations of this clinical trial.

Design outcomes

Primary

MeasureTime frame
Fracture healing rate 24 weeks after surgery;

Secondary

MeasureTime frame
Fracture healing rate 12 weeks after surgery;Joint function;Radiographic reduction;SF-36 scale score;Instrument operation satisfaction assessment;Incidence of adverse events;Incidence of device defects;

Countries

China

Contacts

Public ContactQiang Wang

The Affiliated Sir Run Run Shaw Hospital of Zhejiang University School of Medicine

wangqiang1983@zju.edu.cn+86 150 6889 1971

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026